- Home
- GWRE vs SMMT Comparison
GWRE vs SMMT Comparison
Compare GWRE & SMMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWRE
- SMMT
- Stock Information
- Founded
- GWRE 2001
- SMMT 2003
- Country
- GWRE United States
- SMMT United States
- Employees
- GWRE N/A
- SMMT N/A
- Industry
- GWRE Computer Software: Prepackaged Software
- SMMT Biotechnology: Pharmaceutical Preparations
- Sector
- GWRE Technology
- SMMT Health Care
- Exchange
- GWRE Nasdaq
- SMMT Nasdaq
- Market Cap
- GWRE 15.5B
- SMMT 14.5B
- IPO Year
- GWRE 2012
- SMMT N/A
- Fundamental
- Price
- GWRE $174.53
- SMMT $16.98
- Analyst Decision
- GWRE Buy
- SMMT Strong Buy
- Analyst Count
- GWRE 15
- SMMT 6
- Target Price
- GWRE $195.71
- SMMT $33.33
- AVG Volume (30 Days)
- GWRE 1.2M
- SMMT 1.9M
- Earning Date
- GWRE 12-05-2024
- SMMT 10-30-2024
- Dividend Yield
- GWRE N/A
- SMMT N/A
- EPS Growth
- GWRE N/A
- SMMT N/A
- EPS
- GWRE 0.36
- SMMT N/A
- Revenue
- GWRE $1,035,991,000.00
- SMMT N/A
- Revenue This Year
- GWRE $18.61
- SMMT N/A
- Revenue Next Year
- GWRE $14.70
- SMMT N/A
- P/E Ratio
- GWRE $479.31
- SMMT N/A
- Revenue Growth
- GWRE 12.92
- SMMT N/A
- 52 Week Low
- GWRE $102.66
- SMMT $2.10
- 52 Week High
- GWRE $209.15
- SMMT $33.89
- Technical
- Relative Strength Index (RSI)
- GWRE 35.28
- SMMT 39.64
- Support Level
- GWRE $168.51
- SMMT $17.80
- Resistance Level
- GWRE $176.57
- SMMT $19.18
- Average True Range (ATR)
- GWRE 5.53
- SMMT 1.12
- MACD
- GWRE -2.59
- SMMT -0.00
- Stochastic Oscillator
- GWRE 14.81
- SMMT 15.44
About GWRE Guidewire Software Inc.
Guidewire Software provides software solutions for property and casualty insurers. Flagship product InsuranceSuite is an on-premises system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a cloud-based offering, as well as a variety of other add-on applications.
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.